Assessment of the depression, anxiety, and stress scale (DASS-21) in untreated obstructive sleep apnea (OSA)

Shenooka Nanthakumar, Romola S. Bucks, Timothy C. Skinner, Sergio Starkstein, David Hillman, Alan James, Michael Hunter

Research output: Contribution to journalArticle

2 Citations (Scopus)
207 Downloads (Pure)

Abstract

The assessment of depression in obstructive sleep apnea (OSA) is confounded by symptom overlap. The Depression, Anxiety, and Stress Scale-short form (DASS-21) is a commonly used measure of negative affect, but it not known whether the DASS-21 is suitable for use in an OSA sample. This study compared the fit of Lovibond and Lovibond's (1995) correlated 3-factor structure of the DASS-21 and measurement invariance between a non-OSA and an OSA sample using confirmatory factor analysis. As measurement invariance was not found, to determine the source of non-invariance differential item functioning (DIF) was examined using dMACS. The correlated 3-factor structure (with correlated errors) of the DASS-21 was a better fit in the non-OSA sample. dMACS indicated that there was a degree of DIF for each of the subscales, especially for the Anxiety subscale, in which 2 symptoms (that are also physiological symptoms of OSA) produced lower severity scores in the OSA sample compared with the non-OSA sample. However, the degree of DIF for each of the subscales is not sufficient to cause concern when using the DASS-21; therefore, the total DASS-21 is suitable for use in an OSA sample. Interestingly, the impact of symptom overlap in anxiety symptoms may be reducing anxiety scores because of DIF, which contrasts with the proposed effect of symptom overlap in depression, where it leads to the inflation of depression scores in OSA. This deserves greater consideration in relation to OSA and other clinical disorders or chronic illness conditions with different patterns of overlapping symptoms.

Original languageEnglish
Pages (from-to)1201-1209
Number of pages9
JournalPsychological Assessment
Volume29
Issue number10
DOIs
Publication statusPublished - 1 Oct 2017

Fingerprint

Obstructive Sleep Apnea
Anxiety
Depression
Sleep Apnea Syndromes
Economic Inflation
Statistical Factor Analysis
Chronic Disease

Cite this

@article{0b96df00c3c14dff838a3733e6f3288b,
title = "Assessment of the depression, anxiety, and stress scale (DASS-21) in untreated obstructive sleep apnea (OSA)",
abstract = "The assessment of depression in obstructive sleep apnea (OSA) is confounded by symptom overlap. The Depression, Anxiety, and Stress Scale-short form (DASS-21) is a commonly used measure of negative affect, but it not known whether the DASS-21 is suitable for use in an OSA sample. This study compared the fit of Lovibond and Lovibond's (1995) correlated 3-factor structure of the DASS-21 and measurement invariance between a non-OSA and an OSA sample using confirmatory factor analysis. As measurement invariance was not found, to determine the source of non-invariance differential item functioning (DIF) was examined using dMACS. The correlated 3-factor structure (with correlated errors) of the DASS-21 was a better fit in the non-OSA sample. dMACS indicated that there was a degree of DIF for each of the subscales, especially for the Anxiety subscale, in which 2 symptoms (that are also physiological symptoms of OSA) produced lower severity scores in the OSA sample compared with the non-OSA sample. However, the degree of DIF for each of the subscales is not sufficient to cause concern when using the DASS-21; therefore, the total DASS-21 is suitable for use in an OSA sample. Interestingly, the impact of symptom overlap in anxiety symptoms may be reducing anxiety scores because of DIF, which contrasts with the proposed effect of symptom overlap in depression, where it leads to the inflation of depression scores in OSA. This deserves greater consideration in relation to OSA and other clinical disorders or chronic illness conditions with different patterns of overlapping symptoms.",
keywords = "DASS-21, Depression, Measurement invariance, Negative affect, Obstructive sleep apnea",
author = "Shenooka Nanthakumar and Bucks, {Romola S.} and Skinner, {Timothy C.} and Sergio Starkstein and David Hillman and Alan James and Michael Hunter",
year = "2017",
month = "10",
day = "1",
doi = "10.1037/pas0000401",
language = "English",
volume = "29",
pages = "1201--1209",
journal = "Psychological Assessment",
issn = "1040-3590",
publisher = "American Psychological Association",
number = "10",

}

Assessment of the depression, anxiety, and stress scale (DASS-21) in untreated obstructive sleep apnea (OSA). / Nanthakumar, Shenooka; Bucks, Romola S.; Skinner, Timothy C.; Starkstein, Sergio; Hillman, David; James, Alan; Hunter, Michael.

In: Psychological Assessment, Vol. 29, No. 10, 01.10.2017, p. 1201-1209.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Assessment of the depression, anxiety, and stress scale (DASS-21) in untreated obstructive sleep apnea (OSA)

AU - Nanthakumar, Shenooka

AU - Bucks, Romola S.

AU - Skinner, Timothy C.

AU - Starkstein, Sergio

AU - Hillman, David

AU - James, Alan

AU - Hunter, Michael

PY - 2017/10/1

Y1 - 2017/10/1

N2 - The assessment of depression in obstructive sleep apnea (OSA) is confounded by symptom overlap. The Depression, Anxiety, and Stress Scale-short form (DASS-21) is a commonly used measure of negative affect, but it not known whether the DASS-21 is suitable for use in an OSA sample. This study compared the fit of Lovibond and Lovibond's (1995) correlated 3-factor structure of the DASS-21 and measurement invariance between a non-OSA and an OSA sample using confirmatory factor analysis. As measurement invariance was not found, to determine the source of non-invariance differential item functioning (DIF) was examined using dMACS. The correlated 3-factor structure (with correlated errors) of the DASS-21 was a better fit in the non-OSA sample. dMACS indicated that there was a degree of DIF for each of the subscales, especially for the Anxiety subscale, in which 2 symptoms (that are also physiological symptoms of OSA) produced lower severity scores in the OSA sample compared with the non-OSA sample. However, the degree of DIF for each of the subscales is not sufficient to cause concern when using the DASS-21; therefore, the total DASS-21 is suitable for use in an OSA sample. Interestingly, the impact of symptom overlap in anxiety symptoms may be reducing anxiety scores because of DIF, which contrasts with the proposed effect of symptom overlap in depression, where it leads to the inflation of depression scores in OSA. This deserves greater consideration in relation to OSA and other clinical disorders or chronic illness conditions with different patterns of overlapping symptoms.

AB - The assessment of depression in obstructive sleep apnea (OSA) is confounded by symptom overlap. The Depression, Anxiety, and Stress Scale-short form (DASS-21) is a commonly used measure of negative affect, but it not known whether the DASS-21 is suitable for use in an OSA sample. This study compared the fit of Lovibond and Lovibond's (1995) correlated 3-factor structure of the DASS-21 and measurement invariance between a non-OSA and an OSA sample using confirmatory factor analysis. As measurement invariance was not found, to determine the source of non-invariance differential item functioning (DIF) was examined using dMACS. The correlated 3-factor structure (with correlated errors) of the DASS-21 was a better fit in the non-OSA sample. dMACS indicated that there was a degree of DIF for each of the subscales, especially for the Anxiety subscale, in which 2 symptoms (that are also physiological symptoms of OSA) produced lower severity scores in the OSA sample compared with the non-OSA sample. However, the degree of DIF for each of the subscales is not sufficient to cause concern when using the DASS-21; therefore, the total DASS-21 is suitable for use in an OSA sample. Interestingly, the impact of symptom overlap in anxiety symptoms may be reducing anxiety scores because of DIF, which contrasts with the proposed effect of symptom overlap in depression, where it leads to the inflation of depression scores in OSA. This deserves greater consideration in relation to OSA and other clinical disorders or chronic illness conditions with different patterns of overlapping symptoms.

KW - DASS-21

KW - Depression

KW - Measurement invariance

KW - Negative affect

KW - Obstructive sleep apnea

UR - http://www.scopus.com/inward/record.url?scp=85004130344&partnerID=8YFLogxK

U2 - 10.1037/pas0000401

DO - 10.1037/pas0000401

M3 - Article

VL - 29

SP - 1201

EP - 1209

JO - Psychological Assessment

JF - Psychological Assessment

SN - 1040-3590

IS - 10

ER -